Lectenz Bio品牌介绍

Lectenz Bio品牌介绍

浏览量:104

品牌简介

Lectenz Bio 公司专注于糖生物学研究及工艺相关工具的研究和开发,以简化糖科学研究,促进创新为公司宗旨。公司组建了一支在高性能计算研究及湿式实验室研究领域有着多元化专业背景的团队,用跨学科的专业团队来实现公司的宗旨。目前公司已开发出Lectenz ®(已申请专利)和 GlycoSense™ 平台,为糖生物学的研究提供新的简便的研究方法。 

Lectenz Bio is a company dedicated to providing novel, effective glyco-research and bioprocessing tools. Our mission is to empower innovation by making glycoscience simple. We accomplish this goal by employing a strong team with diverse expertise in high performance computing and wet lab science. It is through this interdisciplinary approach that we developed our patented Lectenz® and GlycoSense™ platforms—offering new, easy to use ways to study glycobiology.

品牌发展史

Lectenz Bio (fka Glycosensors and Diagnostics) 公司是从美国-佐治亚大学(University of Georgia)复合碳水化合物研究中心(Complex Carbohydrate Research Centre)的Robert J. Woods 教授的研究小组中独立出来的。依托于Innovation Gateway创新孵化项目,公司于2009年成立,成为Georgia`s Innovation Crescent生物科技企业之一。2013年,依托于Johnson & Johnson Innovation, JLABS创新孵化项目,公司在加利福尼亚州圣地亚哥建立了卫星业务。2016年,公司从JLABS创新孵化项目中迁出至圣地亚哥科学中心。2017年,公司更名为 Lectenz Bio。 自成立以来,公司与学术界和工业界的专家建立了合作关系,并通过拨款、合约和合伙人关系取得了融资。公司获得了多个奖项、荣誉和认可。这些成就是通过Lectenz ®平台关键技术验证取得的,还有公司研发的GlycoSense™平台,带动Lectenz ®产品线的发展。公司已获得 Lectenz ®平台的技术专利,在保护相关知识产权的同时,公司也在扩大其技术平台的推广和应用。 

Lectenz Bio (fka Glycosensors and Diagnostics) was spun-out from the research group of Prof. Robert J. Woods at the Complex Carbohydrate Research Center, located at the University of Georgia. We established operations in 2009 at Innovation Gateway, home to several biotechnology companies in Georgia’s Innovation Crescent. In 2013, the company established its satellite operations in San Diego, California as a resident company of Johnson & Johnson Innovation, JLABS. In 2016, we graduated from JLABS and relocated to the San Diego Science Center. In 2017, as part of commercialization the company rebranded as Lectenz Bio. Since establishing operations, we formed collaborations with experts in academia and industry and secured non-dilutive funding through grants, contracts, and partnerships. We have received multiple awards, honors, and recognitions. These accomplishments were achieved by validation of key aspects of the Lectenz® platform, addition of our GlycoSenseTM platform, and led to the development of the Lectenz® product pipeline. The company was issued a patent for the Lectenz® platform technology and is expanding and protecting its intellectual property portfolio.


联系我们

无锡药科美生物科技有限公司

联系人:梅先生

手机:13911177784(微信同号)

邮箱:mei@ucallm.com

收藏 点赞(0)
分享
评论列表共有 0 条评论
暂无评论
药科美专注生命科学产品进出口与技术服务